Emmessar Biotech & Nutrition Ltd.

Financial

	Emmessar Biotech&Nut	Link Pharma Chem	Colinz Laboratories
Operational Metrics
Financials
5 yr Average ROE	13.7 %	4.87 %	4.05 %
5yr average Equity Multiplier	1.24	1.96	1.3
5yr Average Asset Turnover Ratio	0.36	1.37	0.7
5yr Avg Net Profit Margin	71.53 %	1.5 %	4.66 %
Price to Book	2.08	1.26	1.58
P/E	51.55	0.0	31.02
5yr Avg Cash Conversion Cycle	68.18 Days	74.76 Days	-0.66 Days
Inventory Days	62.21 Days	54.27 Days	64.79 Days
Days Receivable	10.88 Days	53.6 Days	51.75 Days
Days Payable	199.95 Days	92.46 Days	78.66 Days
5yr Average Interest Coverage Ratio	815.2	3.51	9.16
5yr Avg ROCE	19.97 %	8.64 %	6.01 %
5yr Avg Operating Profit Margin	-101.39 %	5.7 %	6.82 %
5 yr average Debt to Equity	0.0	0.46	0.07
5yr CAGR Net Profit	0.0	n/a	30.39 %
5yr Average Return on Assets	10.86 %	2.49 %	3.14 %
Shareholdings
Promoter Holding	59.53 %	51.49 %	65.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.02 %	0.0	29.56 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0